Implementing sentinel lymph node biopsy programs in developing countries: Challenges and opportunities

World Journal of Surgery

Volumn 35, Issue 6, 2011, Pages 1159-1168

  Keshtgar, Mohammed ^a   Zaknun, John J ^b,c   Sabih, Durre ^d   Lago, Graciela ^e   Cox, Charles E ^f   Leong, Stanley P L ^g   Mariani, Giuliano ^h  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d NISHTAR HOSPITAL   (Pakistan)

^e UNIVERSITY OF URUGUAY   (Uruguay)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; CANCER STAGING; DEVELOPING COUNTRY; EDUCATION; FEMALE; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL COOPERATION; MEDICAL EDUCATION; MELANOMA; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PROGRAM DEVELOPMENT; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; TOTAL QUALITY MANAGEMENT;

BREAST NEOPLASMS; DEVELOPING COUNTRIES; EDUCATION, MEDICAL, CONTINUING; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; INTERNATIONAL COOPERATION; MELANOMA; NEOPLASM STAGING; NEOPLASMS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; QUALITY IMPROVEMENT; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 79956046044     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-0956-3     Document Type: Article

References (67)

1. Curado MP, Edwards B, Shin HR et al (2007) Cancer incidence in five continents, vol IX. International Agency for Research on Cancer (IARC scientific publication no. 160), Lyon, France. http://www-dep.iarc.fr/
2. P Peggy 2008 "Westernizing" women's risks? Breast cancer in lower-income countries N Engl J Med 358 213 216 10.1056/NEJMp0708307
3. Boyle P, Levin B (2008) World cancer report, World Health Organisation. International Agency for Research on Cancer, pp 412-417. Available at http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/index.php. Accessed 7 Jan 2011
4. M Hoffman H De Pinho D Cooper, et al. 2000 Breast cancer incidence and determinants of cancer stage in the Western Cape S Afr Med J 90 1212 1216 11234652 1:STN:280:DC%2BD3M7otlantQ%3D%3D (Pubitemid 32124190)
5. D Vorobiof F Sitas G Vorobiof 2001 Breast cancer incidence in South Africa J Clin Oncol 19 18 Suppl 125s 127s 11560987 1:STN:280: DC%2BD3MrisFCrsA%3D%3D (Pubitemid 32880093)
6. Boyle P, Levin B (2008) World cancer report. World Health Organisation, International Agency for Research on Cancer, pp 408-411
7. D Morton A Cochran J Thompson 2008 The rationale for sentinel-node biopsy in primary melanoma Nat Clin Pract Oncol 5 510 511 18679393 10.1038/ncponc1205
8. D Morton L Wanek J Nizze, et al. 1991 Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic Ann Surg 214 491 501 1953101 10.1097/00000658-199110000-00013 1:STN:280:DyaK38%2FmtFamsg%3D%3D
9. G Lyman A Giuliano M Somerfield, et al. 2005 American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer J Clin Oncol 23 7703 7720 16157938 10.1200/JCO.2005.08.001 (Pubitemid 46291835)
10. Bitten AJ (1999) Radiation detectors. In: Keshtgar M, Waddington W, Lakhani S (eds) The sentinel node in surgical oncology. Springer, Berlin, pp 19-33.
11. Chiesa C, Toscano F, Mariani M et al (2007) Physical performance parameters of intraoperative probes. In: Mariani G, Giuliano AE, Strauss HW (eds) Radioguided surgery-a comprehensive team approach. Springer, New York, pp 12-22
12. T Kim A Giuliano G Lyman 2006 Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis Cancer 106 4 16 16329134 10.1002/cncr.21568 (Pubitemid 43033320)
13. U Veronesi V Galimberti L Mariani, et al. 2005 Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection Eur J Cancer 41 231 237 15661547 10.1016/j.ejca.2004. 05.009 (Pubitemid 40126955)
14. A Purushotham S Upponi M Klevesath, et al. 2005 Morbidity after sentinel lymph mode biopsy in primary breast cancer: results from a randomized controlled trial J Clin Oncol 23 4312 4321 15994144 10.1200/JCO.2005.03.228 (Pubitemid 46209968)
15. R Mansel L Fallowfield M Kissin, et al. 2006 Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst 98 599 609 16670385 10.1093/jnci/djj158 (Pubitemid 43904843)
16. P Del Bianco G Zavagno P Burelli, et al. 2008 Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the Sentinella-GIVOM Italian Randomised Clinical Trial Eur J Surg Oncol 34 508 513 17614245 1:STN:280: DC%2BD1c3mtVKgsQ%3D%3D (Pubitemid 351514885)
17. D Krag S Anderson T Julian, et al. 2007 Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 Randomised Phase III Trial Lancet Oncol 8 881 888 17851130 10.1016/S1470-2045(07)70278-4 1:CAS:528:DC%2BD2sXhtFektbzM (Pubitemid 47488052)
18. Gill G, The SNAC Trial Group of the Royal Australasian College of Surgeons (RACS), NHMRC Clinical Trials Centre (2009) Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16:266-275
19. A Naik J Fey M Gemignani, et al. 2004 The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures Ann Surg 240 462 468 15319717 10.1097/01.sla.0000137130.23530.19 (discussion 468-471) (Pubitemid 39121340)
20. U Veronesi V Galimberti G Paganelli, et al. 2009 Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases Eur J Cancer 45 1381 1388 19128957 10.1016/j.ejca.2008.11.041
21. J Thompson 2002 The Revised American Joint Committee on Cancer staging system for melanoma Semin Oncol 29 361 369 12170439 10.1053/sonc.2002.34115 (Pubitemid 34857884)
22. G Filippakis G Zografos 2007 Contraindications of sentinel lymph node biopsy: are there any really? World J Surg Oncol 5 10 17261174 10.1186/1477-7819-5-10
23. N Hatta R Morita M Yamada, et al. 2005 Implications of popliteal lymph node detected by sentinel lymph node biopsy Dermatol Surg 31 327 330 15841636 10.1111/j.1524-4725.2005.31083 1:CAS:528:DC%2BD28XhtFyhu7bP (Pubitemid 43072989)
24. DL Morton AJ Cochran JF Thompson, et al. 2005 Sentinel node biopsy for early-stage melanoma accuracy and morbidity in MSLT-I, an International Multicenter Trial Ann Surg 242 302 16135917
25. C Rossi G De Salvo G Trifiro, et al. 2006 The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI) J Nucl Med 47 234 241 16455628 (Pubitemid 46780887)
26. K Byrd-Miles E Toombs G Peck 2007 Skin cancer in individuals of African, Asian, Latin American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians J Drugs Dermatol 6 10 16 17373156
27. C Ridgeway T Hieken S Ronan, et al. 1995 Acral lentiginous melanoma Arch Surg 130 88 92 7802583 1:STN:280:DyaK2M7gtVyktA%3D%3D
28. A Phan S Touzet S Dalle, et al. 2006 Acral lentiginous melanoma: a clinicoprognostic study of 126 cases Br J Dermatol 155 561 569 16911282 10.1111/j.1365-2133.2006.07368.x 1:STN:280:DC%2BD28voslSisw%3D%3D (Pubitemid 44215487)
29. K Ishihara T Saida F Otsuka, et al. 2008 Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update Int J Clin Oncol 13 33 41 18307017 10.1007/s10147-007-0751-1 (Pubitemid 351326291)
30. M Guggenheim U Hug F Jung, et al. 2008 Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma Ann Surg 247 687 693 18362633 10.1097/SLA. 0b013e318161312a (Pubitemid 351440621)
31. S Deo A Samaiya P Jain, et al. 2004 Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study Asian J Surg 27 294 298 15564182 10.1016/S1015-9584(09)60054-3 (Pubitemid 39424556)
32. V Parmar R Hawaldar MS Nadkarni, et al. 2009 Low axillary sampling in clinically node-negative operable breast cancer Natl Med J India 22 234 236 20334043 1:STN:280:DC%2BC3c3htVWgug%3D%3D
33. W Waddington M Keshtgar I Taylor, et al. 2007 Radiation safety of the sentinel lymph node technique in breast cancer Eur J Nucl Med 27 377 391 10.1007/s002590050520
34. 99mTc] DTPA-mannosyl-dextran Nucl Med Biol 30 457 464 12831982 10.1016/S0969-8051(03) 00028-3 1:CAS:528:DC%2BD3sXkvVKhsrg%3D (Pubitemid 36776515)
35. 99mTc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping Nucl Med Biol 30 805 810 14698783 10.1016/j.nucmedbio.2003.10.001 1:CAS:528:DC%2BD3sXhtVWisrfP (Pubitemid 38040988)
36. 99mTc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection Nucl Med Biol 28 493 498 11516693 10.1016/S0969-8051(01)00218-9 1:CAS:528:DC%2BD3MXksVGrsbg%3D (Pubitemid 32539397)
37. 99mTc-DTPA-mannosyl-dextran J Nucl Med 42 951 959 11390562 1:CAS:528:DC%2BD3MXmvFOgur8%3D (Pubitemid 32537445)
38. AM Derossis J Fey H Yeung, et al. 2001 A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer J Am Coll Surg 193 473 478 11708502 10.1016/S1072-7515(01)01038-9 1:STN:280:DC%2BD3MnmtlantQ%3D%3D (Pubitemid 33043448)
39. KM McMasters TM Tuttle DJ Carlson, et al. 2000 Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J Clin Oncol 18 2560 2566 10893287 1:STN:280:DC%2BD3czlt1Snuw%3D%3D (Pubitemid 30432522)
40. WK Hung CM Chan M Ying, et al. 2005 Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer Br J Surg 92 1494 1497 16308853 10.1002/bjs.5211 1:STN:280: DC%2BD2Mnjslyluw%3D%3D (Pubitemid 41785287)
41. M Morrow AW Rademaker KP Bethke, et al. 1999 Learning sentinel node biopsy: results of a prospective randomized trial of two techniques Surgery 126 714 720 10520920 10.1016/S0039-6060(99)70127-3 1:STN:280:DyaK1MvkvFagsg%3D%3D (Pubitemid 29473174)
42. MRS Keshtgar PJ Ell 2002 Clinical role of sentinel lymph node biopsy in breast cancer Lancet Oncol 3 105 110 11905458 10.1016/S1470-2045(02)00652-6 (Pubitemid 34162981)
43. DL Morton JF Thompson R Essner, et al. 1999 Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group Ann Surg 230 453 563 10522715 10.1097/00000658-199910000-00001 1:STN:280:DyaK1MvltVGmsg%3D%3D (Pubitemid 30191840)
44. B Fisher JH Jeong S Anderson, et al. 2002 Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Engl J Med 347 567 575 12192016 10.1056/NEJMoa020128
45. JM East CSP Valentine E Kanchev, et al. 2009 Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis BMC Surg 9 2 19173714 10.1186/1471-2482-9-2
46. H Ahmadzadehfar E Habibi K Biermann, et al. 2007 Impact of injection for sentinel lymph node scintigraphy in breast cancer: is the quadrant of superficial tracer injection of importance? Eur J Nucl Med Mol Imag 34 Suppl 2 S225
47. G Bonadonna P Valagussa C Brambilla, et al. 1993 Preoperative chemotherapy in operable breast cancer Lancet 341 1485 8099186 10.1016/0140-6736(93)90933-8 1:STN:280:DyaK3s3nsFWitA%3D%3D (Pubitemid 23161489)
48. KE Kilbride MC Lee AV Nees, et al. 2008 Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence Ann Surg Oncol 15 3252 3258 18784961 10.1245/s10434-008-0136-3
49. MZ Papa D Zippel B Kaufman, et al. 2008 Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer J Surg Oncol 98 403 406 18683193 10.1002/jso.21128
50. JM Classe V Bordes L Campion, et al. 2009 Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study J Clin Oncol 27 726 732 19114697 10.1200/JCO.2008.18.3228
51. C Tausch P Konstantiniuk F Kugler, et al. 2008 Austrian Sentinel Node Study Group. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group Ann Surg Oncol 15 3378 3383 19097267 10.1245/s10434-008-0041-9
52. Viale G, Mazzarol G, Maiorano E (2007) Histopathology of sentinel lymph node. In: Mariani G, Giuliano AE, Strauss HW (eds) Radioguided surgery-a comprehensive team approach. Springer, New York, pp 190-194
53. Amersi F, Giuliano A, Hoon D (2007) Molecular assessment of sentinel lymph nodes. In: Mariani G, Giuliano AE, Strauss HW (eds) Radioguided surgery-a comprehensive team approach. Springer, New York, pp 206-217
54. A Romanini G Manca D Pellegrino, et al. 2005 Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome Ann Oncol 16 1832 1840 16107497 10.1093/annonc/mdi372 1:STN:280: DC%2BD2MrlvFGmuw%3D%3D (Pubitemid 41631249)
55. J Ulrich B Bonnekoh R Bockelmann, et al. 2004 Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients Eur J Cancer 40 2812 2819 15571965 10.1016/j.ejca.2004.08.009 1:CAS:528:DC%2BD2cXhtVahurjJ (Pubitemid 39574736)
56. M Manzotti P Dell'Orto P Maiaonneuve, et al. 2001 Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes Int J Cancer 95 307 312 11494230 10.1002/1097-0215(20010920)95:5<307::AID-IJC0153>3.0. CO;2-Q 1:CAS:528:DC%2BD3MXmslSlsb8%3D (Pubitemid 32847041)
57. W Gillanders K Mikhitarian R Hebert, et al. 2004 Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study Ann Surg 239 828 837 15166962 10.1097/01.sla.0000128687.59439.d6 (discussion 837-840) (Pubitemid 38669433)
58. A Nissan D Jager M Roystacher, et al. 2006 Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients Br J Cancer 94 681 685 16495929 1:STN:280:DC%2BD287jsVygtA%3D%3D (Pubitemid 43361899)
59. K Mikhitarian R Martin M Mitas, et al. 2005 Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study Surgery 138 474 481 16213901 10.1016/j.surg.2005.07.001 (Pubitemid 41415575)
60. P Gimbergues M Dauplat A Cayre, et al. 2007 Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen Risk Category Eur J Surg Oncol 33 16 22 17071045 1:STN:280:DC%2BD2s%2Flt1Wqsg%3D%3D (Pubitemid 46131872)
61. D Chicken G Kocjan M Falzon, et al. 2006 Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer Br J Surg 93 572 576 16550634 10.1002/bjs.5289 1:STN:280:DC%2BD283gvFChsA%3D%3D
62. V Soo P Shen R Pichardo, et al. 2007 Intraoperative evaluation of sentinel lymph nodes for metastatric melanoma by imprint cytology Ann Surg Oncol 14 1612 1617 17287998 10.1245/s10434-006-9272-9 (Pubitemid 46790988)
63. Nicosia S, Cox C (2007) Frozen section and imprint cytology in sentinel lymph node biopsy for breast cancer. In: Mariani G, Giuliano AE, Strauss HW (eds) Radioguided surgery-a comprehensive team approach. Springer, New York, pp 48-49
64. G Viale MG Mastropasqua E Maiorano, et al. 2006 Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience Virchows Arch 448 241 247 16362823 10.1007/s00428-005-0103-3 (Pubitemid 43357638)
65. G Viale P Dell'Orto MO Biasi, et al. 2008 Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription- polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients Ann Surg 247 136 142 18156933 10.1097/SLA.0b013e318157d22b
66. Whitman E (2007) Training and credentialing for radioguided surgery. In: Mariani G, Giuliano AE, Strauss HW (eds) Radioguided surgery-a comprehensive team approach. Springer, New York, pp 45-54
67. F MacNeill 2007 New start: the UK SLNB training programme-a progress report Bull R Coll Surg Engl 89 60 68 10.1308/147363507X173418